OPTX) Enabling Optics for Blindness
ROCHESTER, NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Syntec Optics, a scientific technical instruments, aerospace and defense optics provider that has...
Ranchero Provides Update on the Disposition of Its Santa
VANCOUVER, British Columbia, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ranchero Gold Corp. (“Ranchero” or the “Company”) (TSX.V:RNCH) is pleased to announce that...
Blackwells Capital Releases its Vision for the Future of
Excerpt from its Upcoming Investor Presentation Available at www.TheFutureOfDisney.com Blackwells’ CIO Releases Video Discussing Key Aspects of its Campaign Available At www.TheFutureOfDisney.com and...
BeyondSpring Regains Compliance with Nasdaq Minimum Bid
FLORHAM PARK, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company...
Rodedawg Intl. Ind, Inc. (OTC: RWGI) Signs Exclusive
COSTA MESA, CA, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Rodedawg International Industries, Inc. (OTC: RWGI) proudly announces the Company, through our wholly...
Hampton Financial Corporation – Proposed Private Placement
TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Hampton Financial Corporation (“Hampton” or the “Company”, TSXV:HFC) advises that it proposes to sell, in a non-brokered...
Auddia Announces Reverse Stock Split
BOULDER, CO, Feb. 23, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Auddia Inc., (“Auddia” or the “Company”) (Nasdaq: AUUD, AUUDW), a proprietary...
Celularity Announces 1-for-10 Reverse Stock Split
FLORHAM PARK, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Celularity, Inc. (Nasdaq: CELU; CELUW) (“Celularity”), a biotechnology company developing allogeneic cell therapies...
Bio-Path Holdings Announces 1-for-20 Reverse Stock Split
HOUSTON, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH) (the “Company”), a biotechnology company leveraging its proprietary DNAbilize® antisense...
Madrigal Pharmaceuticals Reports Inducement Grants under
CONSHOHOCKEN, Pa., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis...
American Rare Earths Announces A$13.5m Placement to advance
Highlights Firm commitments received via an institutional placement to raise gross proceeds of A$13.5 million at an issue price of A$0.30 per shareStrong...
Allied Announces Renewal of Normal Course Issuer Bid
TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Allied Properties Real Estate Investment Trust (“Allied”) (TSX:AP.UN) today announced that it has received approval...
